TY - JOUR
T1 - Feasibility of implementing an intervention in general practice for deprescribing of glucose-lowering medication in overtreated elderly
AU - Andriessen, Charlotte
AU - Blom, Marieke T.
AU - van Hoek, Beryl A. C. E.
AU - de Boer, Anna W.
AU - Denig, Petra
AU - Herings, Ron
AU - de Rooij-Peek, Angela
AU - van Marum, Rob J.
AU - Hugtenburg, Jacqueline G.
AU - van Raalte, Daniël
AU - van Bloemendaal, Liselotte
AU - Nijpels, Giel
AU - Westerman, Marjan J.
AU - Vos, Rimke C.
AU - Elders, Petra J. M.
N1 - Publisher Copyright:
© 2025 The Author(s).
PY - 2025/10/1
Y1 - 2025/10/1
N2 - Background Elderly patients with Type 2 diabetes (T2D) are frequently overtreated with glucose-lowering medication. Objective This feasibility study evaluated the implementation of a deprescribing programme (DPP) for general practices, consisting of education, a patient selection tool, practice visits, and an expert support panel, before scaling it in a randomized controlled trial. Methods Quantitative evaluation included the number of patients with T2D eligible for deprescribing using medical records and study progress data. Qualitative evaluation entailed the analysis of minutes made during training, and interviews with health care providers (HCPs). The extended normalization process theory guided analysis. Results In 10 practices, 55 out of 65 eligible patients were deprescribed glucose-lowering medication, with 22 restarts. Most execution steps were perceived as the practice nurse's responsibility, whereas the general practitioner needed to approve the deprescribing. Practice nurses found the educational training, including peer-to-peer sessions and practice visits, supportive of integrating deprescribing into practice. DPP procedures and tasks not part of the regular care process were not consistently performed. The DPP was adapted to minimize study tasks for HCPs and align study procedures to existing routine procedures. Conclusion Implementation of a DPP in general practice requires education, practice visits, and alignment of DPP components to regular care.
AB - Background Elderly patients with Type 2 diabetes (T2D) are frequently overtreated with glucose-lowering medication. Objective This feasibility study evaluated the implementation of a deprescribing programme (DPP) for general practices, consisting of education, a patient selection tool, practice visits, and an expert support panel, before scaling it in a randomized controlled trial. Methods Quantitative evaluation included the number of patients with T2D eligible for deprescribing using medical records and study progress data. Qualitative evaluation entailed the analysis of minutes made during training, and interviews with health care providers (HCPs). The extended normalization process theory guided analysis. Results In 10 practices, 55 out of 65 eligible patients were deprescribed glucose-lowering medication, with 22 restarts. Most execution steps were perceived as the practice nurse's responsibility, whereas the general practitioner needed to approve the deprescribing. Practice nurses found the educational training, including peer-to-peer sessions and practice visits, supportive of integrating deprescribing into practice. DPP procedures and tasks not part of the regular care process were not consistently performed. The DPP was adapted to minimize study tasks for HCPs and align study procedures to existing routine procedures. Conclusion Implementation of a DPP in general practice requires education, practice visits, and alignment of DPP components to regular care.
KW - elderly
KW - general practice
KW - hypoglycaemia
KW - implementation
KW - quality improvement
KW - type 2 diabetes
UR - https://www.scopus.com/pages/publications/105015072013
U2 - 10.1093/fampra/cmaf064
DO - 10.1093/fampra/cmaf064
M3 - Article
C2 - 40910519
SN - 0263-2136
VL - 42
JO - Family practice
JF - Family practice
IS - 5
M1 - cmaf064
ER -